1. Home
  2. TW vs BNTX Comparison

TW vs BNTX Comparison

Compare TW & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tradeweb Markets Inc.

TW

Tradeweb Markets Inc.

N/A

Current Price

$104.74

Market Cap

22.9B

Sector

Finance

ML Signal

N/A

Logo BioNTech SE

BNTX

BioNTech SE

N/A

Current Price

$91.76

Market Cap

24.8B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TW
BNTX
Founded
1996
2008
Country
United States
Germany
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.9B
24.8B
IPO Year
2019
2019

Fundamental Metrics

Financial Performance
Metric
TW
BNTX
Price
$104.74
$91.76
Analyst Decision
Buy
Buy
Analyst Count
12
11
Target Price
$140.83
$137.40
AVG Volume (30 Days)
1.1M
1.4M
Earning Date
02-05-2026
11-03-2025
Dividend Yield
0.46%
N/A
EPS Growth
40.82
N/A
EPS
2.93
N/A
Revenue
$1,992,479,000.00
$3,698,814,972.00
Revenue This Year
$22.56
$2.36
Revenue Next Year
$11.04
N/A
P/E Ratio
$35.44
N/A
Revenue Growth
22.37
3.70
52 Week Low
$101.71
$81.20
52 Week High
$152.65
$129.27

Technical Indicators

Market Signals
Indicator
TW
BNTX
Relative Strength Index (RSI) 42.68 32.13
Support Level $103.60 $94.52
Resistance Level $108.88 $97.35
Average True Range (ATR) 2.19 2.33
MACD -0.24 -0.42
Stochastic Oscillator 21.44 2.64

Price Performance

Historical Comparison
TW
BNTX

About TW Tradeweb Markets Inc.

Founded in 1998 and headquartered in New York City, Tradeweb Markets is a leading fixed-income trading platform. While it does offer electronic processing for some voice-negotiated trades, the company focuses primarily on providing electronic trading networks that connect broker/dealers, institutional clients, and retail customers. While the company offers trading in a wide variety of products, the bulk of its business is in US and European government debt, mortgage-backed securities, interest-rate swaps, and US and international corporate bonds. The firm also sells fixed-income trading and price data, primarily through a deal with Refinitiv's Eikon service.

About BNTX BioNTech SE

BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.

Share on Social Networks: